Pages that link to "Q26752518"
Jump to navigation
Jump to search
The following pages link to Targeting NK Cells for Anticancer Immunotherapy: Clinical and Preclinical Approaches (Q26752518):
Displaying 28 items.
- Crosstalk between Innate Lymphoid Cells and Other Immune Cells in the Tumor Microenvironment (Q28077126) (← links)
- Immunological and Translational Aspects of NK Cell-Based Antitumor Immunotherapies (Q28079180) (← links)
- Large-scale isolation and cytotoxicity of extracellular vesicles derived from activated human natural killer cells (Q36317164) (← links)
- A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity. (Q38694446) (← links)
- Natural Killers Are Made Not Born: How to Exploit NK Cells in Lung Malignancies. (Q38872473) (← links)
- The ever-expanding myokinome: discovery challenges and therapeutic implications (Q38951385) (← links)
- Radiotherapy and immunotherapy: a beneficial liaison? (Q39017268) (← links)
- Current progress in innovative engineered antibodies (Q40077818) (← links)
- High NKG2A expression contributes to NK cell exhaustion and predicts a poor prognosis of patients with liver cancer (Q40333142) (← links)
- In Vitro Culture with Interleukin-15 Leads to Expression of Activating Receptors and Recovery of Natural Killer Cell Function in Acute Myeloid Leukemia Patients (Q41269711) (← links)
- Glatiramer Acetate, Dimethyl Fumarate, and Monomethyl Fumarate Upregulate the Expression of CCR10 on the Surface of Natural Killer Cells and Enhance Their Chemotaxis and Cytotoxicity. (Q41497471) (← links)
- Tackling Cancer Resistance by Immunotherapy: Updated Clinical Impact and Safety of PD-1/PD-L1 Inhibitors (Q47712161) (← links)
- An IL-15 superagonist/IL-15Rα fusion complex protects and rescues NK cell-cytotoxic function from TGF-β1-mediated immunosuppression. (Q48119165) (← links)
- Natural Killer Cell-Based Immunotherapy in Gynecologic Malignancy: A Review. (Q49724715) (← links)
- Effect of NK cell immunotherapy on immune function in patients with hepatic carcinoma: A preliminary clinical study. (Q52779233) (← links)
- Tumour muscle crosstalk more as regulation of muscle wasting - role of exercise. (Q54269025) (← links)
- Neuroblastoma Cell Lines Are Refractory to Genotoxic Drug-Mediated Induction of Ligands for NK Cell-Activating Receptors. (Q54941625) (← links)
- Targeting Checkpoint Receptors and Molecules for Therapeutic Modulation of Natural Killer Cells (Q56889003) (← links)
- Viral and Nonviral Engineering of Natural Killer Cells as Emerging Adoptive Cancer Immunotherapies (Q57300237) (← links)
- Expression of a Recombinant High Affinity IgG Fc Receptor by Engineered NK Cells as a Docking Platform for Therapeutic mAbs to Target Cancer Cells (Q60046090) (← links)
- Cancer Immunotherapy Based on Natural Killer Cells: Current Progress and New Opportunities. (Q64987872) (← links)
- Rocaglamide enhances NK cell-mediated killing of non-small cell lung cancer cells by inhibiting autophagy (Q89406920) (← links)
- Adenosinergic signaling as a target for natural killer cell immunotherapy (Q90704170) (← links)
- Radiotherapy as a Backbone for Novel Concepts in Cancer Immunotherapy (Q92441858) (← links)
- A Natural Impact: NK Cells at the Intersection of Cancer and HIV Disease (Q93047632) (← links)
- NK Cell-Based Immunotherapies in Cancer (Q94570971) (← links)
- Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma (Q97067036) (← links)
- Immune checkpoint molecules in natural killer cells as potential targets for cancer immunotherapy (Q101120982) (← links)